心玮医疗-B(6609.HK)今日早盘一度大涨14.1%至57.85港元。心玮医疗昨日晚间公告，集团预期于截至2025年12月31日止年度录得收益介乎约4亿元(人民币，下同)至4.1亿元，较截至2024年12月31日止年度的收益2.78亿元增加至少43.9%。集团亦预计于报告期间录得除税前利润约8000万元，与截至2024年12月31日止年度的除税前净亏损1200万元比较有大幅增长。 公司同日亦宣布，集团开发的自膨式颅内药物洗脱支架的注册申请已获中华人民共和国国家药品监督管理局受理。自膨式颅内药物洗脱支架用于颅内动脉粥样硬化性狭窄的治疗，对狭窄和梗阻的管腔具有支撑和开通的作用，并且能有效预防支架内的管腔再狭窄。根据公开信息查询，目前全球范围内尚无类似产品获批上市，公司对该类型产品的研发进度处于行业内领先水平。(格隆汇)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.